Truvestments Capital LLC Editas Medicine, Inc. Transaction History

Truvestments Capital LLC

$363 Million
Q3 2024

A detailed history of Truvestments Capital LLC transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Truvestments Capital LLC holds 61 shares of EDIT stock, worth $79. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$79

% of portfolio

0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$3.39 - $5.96 $206 - $363	61 New	61 $0
Q1 2023 May 12, 2023	SELL	$7.03 - $11.53 $260 - $426	-37 Reduced 37.76%	61 $0
Q2 2022 Aug 09, 2022	BUY	$9.99 - $21.35 $979 - $2,092	98 New	98 $1,000
Q1 2022 May 02, 2022	SELL	$14.08 - $27.63 $1,379 - $2,707	-98 Closed	0 $0
Q1 2021 May 18, 2021	SELL	$39.71 - $90.58 $1,231 - $2,807	-31 Reduced 24.03%	98 $4,000
Q4 2020 Feb 17, 2021	BUY	$27.07 - $84.35 $3,492 - $10,881	129 New	129 $9,000
Q3 2020 Nov 13, 2020	SELL	$28.06 - $37.16 $3,619 - $4,793	-129 Closed	0 $0
Q2 2020 Aug 06, 2020	BUY	$18.5 - $34.34 $2,386 - $4,429	129 New	129 $3,000
Q4 2019 Jan 29, 2020	SELL	$19.49 - $32.63 $4,346 - $7,276	-223 Closed	0 $0
Q3 2019 Oct 10, 2019	SELL	$22.49 - $26.81 $539 - $643	-24 Reduced 9.72%	223 $5,000
Q1 2019 Apr 12, 2019	SELL	$19.43 - $26.41 $77 - $105	-4 Reduced 1.59%	247 $6,000
Q3 2018 Oct 22, 2018	BUY	$27.65 - $38.39 $6,940 - $9,635	251 New	251 $8,000

Others Institutions Holding EDIT

# of Institutions

248

Shares Held

57M

Call Options Held

410K

Put Options Held

394K

Black Rock Inc. New York, NY

7.78M
Shares

$10.2 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

6.68M
Shares

$8.75 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

4.9M
Shares

$6.42 Million
0.62% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.35M
Shares

$4.39 Million
0.01% of portfolio
State Street Corp Boston, MA

2.46M
Shares

$3.23 Million
0.0% of portfolio

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $90M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Truvestments Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Truvestments Capital LLC with notifications on news.

Account